A scientific advisory panel voted 8 to 7 to recommend that the strongest possible safety warning be added to the labeling for certain drugs used to treat attention-deficit/hyperactivity disorder. A panel talks about what’s behind this recommendation and how these drugs are being used and abused.

Guests

  • Dr. Steven Nissen Cardiologist at the Cleveland Clinic and a member of the FDA advisory panel that voted to recommend the strongest possible safety warning on certain drugs used to treat AD/HD
  • Dr. Jay Salpekar Director of outpatient psychiatry services at Children's National Medical Center
  • Dr. Lawrence H. Diller Behavioral developmental pediatrician practicing in Walnut Creek, Ca. and a member of the clinical faculty at the University of California--San Francisco. Author of "Running on Ritalin."
  • Lew Mills Psychotherapist in private practice in San Francisco who is taking medication for AD/HD, as are his two children

Related Links

Comments

comments powered by Disqus
Most Recent Shows